###begin article-title 0
###xml 38 47 <span type="species:ncbi:7955">zebrafish</span>
Generation of FGF reporter transgenic zebrafish and their utility in chemical screens
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 162 167 <span type="species:ncbi:10090">mouse</span>
###xml 172 181 <span type="species:ncbi:7955">zebrafish</span>
Fibroblast Growth Factors (FGFs) represent a large family of secreted proteins that are required for proper development and physiological processes. Mutations in mouse and zebrafish FGFs result in abnormal embryogenesis and lethality. A key to understanding the precise role for these factors is to determine their spatial and temporal activity during embryogenesis.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 14 45 14 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dual Specificity Phosphatase 6 </italic>
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6</italic>
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mkp3</italic>
###xml 133 139 133 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 248 254 248 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP</italic>
###xml 279 295 279 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 430 435 430 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf3 </italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8 </italic>
###xml 561 565 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf </italic>
###xml 1125 1138 1125 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Fli1:EGFP)</italic>
###xml 1138 1139 1138 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 1138 1140 1138 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1</sup>
###xml 166 175 <span type="species:ncbi:7955">zebrafish</span>
Expression of Dual Specificity Phosphatase 6 (dusp6, also known as Mkp3) is controlled by FGF signalling throughout development. The Dusp6 promoter was isolated from zebrafish and used to drive expression of destabilized green fluorescent protein (d2EGFP) in transgenic embryos (Tg(Dusp6:d2EGFP)). Expression of d2EGFP is initiated as early as 4 hours post-fertilization (hpf) within the future dorsal region of the embryo, where fgf3 and fgf8 are initially expressed. At later stages, d2EGFP is detected within structures that correlate with the expression of Fgf ligands and their receptors. This includes the mid-hindbrain boundary (MHB), pharyngeal endoderm, otic vesicle, hindbrain, and Kupffer's vesicle. The expression of d2EGFP is under the control of FGF signalling as treatment with FGF Receptor (FGFR) inhibitors results in the suppression of d2EGFP expression. In a pilot screen of commercially available small molecules we have evaluated the effectiveness of the transgenic lines to identify specific FGF inhibitors within the class of indolinones. These compounds were counter screened with the transgenic line Tg(Fli1:EGFP)y1, that serves as an indirect read-out for Vascular Endothelial Growth Factor (VEGF) signalling in order to determine the specificity between related receptor tyrosine kinases (RTKs). From these assays it is possible to determine the specificity of these indolinones towards specific RTK signalling pathways. This has enabled the identification of compounds that can block specifically the VEGFR or the FGFR signalling pathway.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 38 47 <span type="species:ncbi:7955">zebrafish</span>
The generation of transgenic reporter zebrafish lines has allowed direct visualization of FGF signalling within the developing embryo. These FGF reporter transgenic lines provide a tool to screen for specific compounds that can distinguish between two conserved members of the RTK family.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 556 557 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 731 732 731 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 733 734 733 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1117 1118 1113 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1119 1120 1115 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
The complex process of embryogenesis is directed by the regulation of signalling pathways that are achieved in part by the activity of a variety of secreted ligands. Thus understanding the temporal and spatial activity of signalling peptides is key to determining the role for these factors in controlling cellular fates. For example, Fibroblast Growth Factors (FGFs), a family of secreted glycoproteins, perform crucial functions that include the establishment of embryo polarity, the formation of organizing centres, and the induction of limb outgrowth [1-3]. These ligands are expressed in discrete domains during development and their actions are restricted to cells that express integral membrane proteins that can bind FGFs [2,4]. The FGF receptors (FGFRs) are members of the receptor tyrosine kinase (RTK) class of transmembrane proteins and activate several signalling cascades, including the phospholipase C gamma (PLC-gamma), phosphatidylinositol-3 kinase (PI3K) which activates Akt/protein kinase B, and Ras which activates extracellular signal-regulated protein kinase (ERK, also known as MAPK) pathways [5,6]. FGF activity results in the control of gene expression through the modification of transcription factors by activated ERKs and AKT. As a consequence of altered gene expression, cellular proliferation, survival and fate determination can be governed by FGF activity. How FGFs control gene expression and the nature of the genes that they regulate during development is still not completely established.
###end p 9
###begin p 10
###xml 530 545 530 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 574 575 574 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 516 521 <span type="species:ncbi:10090">mouse</span>
###xml 523 528 <span type="species:ncbi:9031">chick</span>
###xml 530 544 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 549 558 <span type="species:ncbi:7955">zebrafish</span>
One step towards defining FGF target genes is to determine the temporal and spatial activity of FGFs during development. This will provide an activity map of where and when these factors act to control developmental processes. Since activation of FGF signalling results in the phosphorylation of Erk, one approach to illustrate FGF activity during development has been to detect the spatial and temporal presence of phosphorylated ERKs in the embryo. This has resulted in mapping the location of FGF activity during mouse, chick, Xenopus laevis and zebrafish embryogenesis [7-12]. While these studies provide a detailed analysis of FGF activity during development, it is not possible to visualize FGF activity in the live embryo and observe the dynamic changes in FGF signalling as the embryo develops.
###end p 10
###begin p 11
###xml 86 170 86 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dual Specificity Phosphatase 6, dusp6 (also known as Map Kinase Phosphatase 3, mkp3)</italic>
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sef</italic>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8 </italic>
###xml 244 249 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf3 </italic>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 454 460 454 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 598 604 598 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 733 739 733 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 813 819 813 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 873 879 873 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 1041 1047 1041 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 61 70 <span type="species:ncbi:7955">zebrafish</span>
###xml 670 675 <span type="species:ncbi:10090">mouse</span>
We have previously identified several FGF regulated genes in zebrafish, including the Dual Specificity Phosphatase 6, dusp6 (also known as Map Kinase Phosphatase 3, mkp3), and Sef, two genes that exhibit almost identical expression to fgf8 and fgf3 during development [11,13-15]. Dusp6 functions to dephosphorylate activated p44 and p42 ERKs and over-expression of Dusp6 results in the suppression of FGF activity in the embryo [11,16-18]. Expression of dusp6 was suppressed in embryos treated with SU5402, an FGFR inhibitor, or by the ectopic expression of dominant negative FGFR, indicating that dusp6 transcription is regulated by FGFs [11,16-18]. Genetic studies in mouse have identified the requirement for FGFRs in maintaining Dusp6 expression, as loss of either FGFR1 or FGFR2 resulted in the depletion of Dusp6 transcripts [19]. It is clear from these studies that Dusp6 expression is regulated by FGF ligands and receptors, however it has been controversial as to which signalling pathway downstream of the receptor is required for Dusp6 gene transcription.
###end p 11
###begin p 12
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 420 426 420 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 687 693 687 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 29 34 <span type="species:ncbi:9031">chick</span>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
###xml 46 55 <span type="species:ncbi:7955">zebrafish</span>
###xml 216 221 <span type="species:ncbi:9031">chick</span>
###xml 480 485 <span type="species:ncbi:10090">mouse</span>
###xml 490 495 <span type="species:ncbi:9031">chick</span>
###xml 549 554 <span type="species:ncbi:10090">mouse</span>
Experiments described in the chick, mouse and zebrafish embryos have provided clues that Dusp6 gene regulation is context dependent [11,16-18,20,21]. In several studies, the PI3K inhibitor, LY294002, was used in the chick limb bud to show that blocking the PI3K/AKT pathway results in the suppression of Dusp6 expression within the distal limb bud [17,20]. Likewise, implantation beads soaked in LY294002 could suppress Dusp6 expression within the mid-hindbrain boundary (MHB) in mouse and chick embryos [18,21]. In contrast, genetic studies in the mouse has revealed that the PI3K pathway is not required as knock-out of PDK1, an upstream activator of PI3K, still allowed expression of Dusp6 albeit in a disorganized fashion [20].
###end p 12
###begin p 13
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 249 255 249 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 348 354 348 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 551 557 551 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 635 641 635 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 713 719 713 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 852 858 852 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 901 903 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 957 963 957 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 1063 1065 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1190 1196 1190 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 273 278 <span type="species:ncbi:9031">chick</span>
###xml 880 885 <span type="species:ncbi:9031">chick</span>
###xml 1044 1049 <span type="species:ncbi:9031">chick</span>
Analysis of the RAS/MAPK pathway under similar experimental conditions indicates that this pathway is also important for Dusp6 gene expression. For instance, the implantation of beads soaked with PD184352, a specific inhibitor of Mek can also block Dusp6 expression in the chick limb bud and somites, implicating the RAS/MAPK pathway in regulating Dusp6 expression [16,20,22]. Further, over-expression of Dusp6 itself, which would result in the removal of activated ERKs and hence the shutdown the RAS/MAPK pathway, resulted in the down regulation of Dusp6 transcription [11,20]. Although these studies highlight the complex nature of Dusp6 gene regulation downstream of the FGF receptor it is however clear that Dusp6 is a direct target of FGF signalling. This concept is supported by the fact that the presence of Erk phosphorylation correlates with Dusp6 expression throughout chick embryogenesis [12]. A detailed map of ERK activation was described and Dusp6 expression was found to colocalize with activated ERKs in all tissues throughout chick development [12]. Thus FGF activity can be directly measured by either the presence of phosphorylated ERKs or indirectly by the presence of Dusp6 transcripts.
###end p 13
###begin p 14
###xml 189 197 189 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex utero</italic>
###xml 300 307 300 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 541 547 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 568 575 568 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP </italic>
###xml 804 807 804 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sef</italic>
###xml 809 824 809 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sprouty4, pea3 </italic>
###xml 828 832 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">erm </italic>
###xml 853 854 853 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 163 172 <span type="species:ncbi:7955">zebrafish</span>
###xml 353 362 <span type="species:ncbi:7955">zebrafish</span>
The generation of transgenic lines that express fluorescent reporters in response to FGFs would allow live visualization of FGF activity during development. Since zebrafish embryos develop ex utero, the direct visualization of d2EGFP in the embryos can provide an indirect biosensor for FGF activity in vivo. In this report we have generated transgenic zebrafish lines that expresses a destabilized form of Green Fluorescent Protein (d2EGFP) under the control of active FGF signalling. To achieve this we isolated the promoter region of the dusp6 gene and fused it to d2EGFP reporter gene. d2EGFP fluorescence can be visualised in transgenic embryos within multiple tissues where activated ERKs (phosphorylated) have been detected, and where expression of FGF ligands, receptors and target genes such as sef, sprouty4, pea3 and erm have been described [9,10,13,15,23-31].
###end p 14
###begin p 15
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 476 484 476 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
###xml 134 143 <span type="species:ncbi:7955">zebrafish</span>
The zebrafish has become a viable model organism for chemical screens [32-34]. With the generation of fluorescent transgenic reporter zebrafish lines it is possible to discover specific molecules that can alter differentiation events during organogenesis [35]. We have validated the FGF reporter lines as tools to identify novel FGF modulators and in counter screens it is possible to determine compound specificity towards two closely related RTK pathways. The generation of in vivo reporters for FGF activity will provide a valuable tool to screen for genes or chemicals that modulate FGF signalling.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
Generation of transgenic FGF reporter lines
###end title 17
###begin p 18
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 136 142 136 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 270 276 270 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP</italic>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 541 547 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 684 689 684 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1094 1110 1094 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 1110 1112 1110 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 1114 1116 1114 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 1110 1117 1110 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6-<italic>pt</italic>9</sup>
###xml 1117 1118 1117 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">)</italic>
###xml 1160 1176 1160 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 1176 1178 1176 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 1176 1179 1176 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6</sup>
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
###xml 566 575 <span type="species:ncbi:7955">zebrafish</span>
###xml 1429 1438 <span type="species:ncbi:7955">zebrafish</span>
The zebrafish Dusp6 gene locus was identified by PCR screening a BAC library from Genome Systems. The BAC clone contained the full gene Dusp6 locus, and a 10 Kb fragment that includes the 5' untranslated sequence within exon I was subcloned into a vector containing the d2EGFP, a gene that encodes a destabilised green fluorescent protein that has a two hour half-life (Figure 1A) [36]. Since FGF signalling during embryogenesis is dynamic, we reasoned that a destabilized form of EGFP would likely recapitulate the endogenous expression of dusp6 mRNA. 1-cell stage zebrafish embryos were co-injected with the transgenic DNA construct and I-Sce 1 meganuclease as described by Thermes et al. to generate transgenic lines [37]. Injected embryos were raised to adulthood and screened for potential germline carriers by d2EGFP expression. Ten founder transgenic animals were identified in the F1 generation. While d2EGFP expression levels differed between each of the transgenic lines, the expression patterns were identical between the transgenic lines. We maintained four of the strongest lines (Tg(Dusp6:d2EGFP)pt6-pt9), and for this study we utilized the line Tg(Dusp6:d2EGFP)pt6. We have generated homozygous lines for several of the transgenes and observed the expected Mendelian inheritance. Further, there were no deleterious effects noted in transgenic animals, suggesting that insertion of the DNA construct did not impact zebrafish growth and development.
###end p 18
###begin p 19
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Generation of <italic>Dusp6 </italic>DNA construct and expression of d2EGFP in transgenic embryos</bold>
###xml 82 86 82 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 186 198 186 198 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B, E, &amp; H) </bold>
###xml 198 204 198 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 225 228 225 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B)</bold>
###xml 235 238 235 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E)</bold>
###xml 258 262 258 262 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 262 274 262 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP mRNA </italic>
###xml 302 320 302 320 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D, F, G, I, &amp; J) </bold>
###xml 320 336 320 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 336 338 336 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 336 340 336 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 356 359 356 359 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D)</bold>
###xml 373 380 373 380 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F &amp; G)</bold>
###xml 393 401 393 401 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(I &amp; J) </bold>
###xml 408 418 408 418 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B-F &amp; I) </bold>
###xml 440 448 440 448 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(H &amp; J) </bold>
###xml 175 184 <span type="species:ncbi:7955">zebrafish</span>
Generation of Dusp6 DNA construct and expression of d2EGFP in transgenic embryos. (A) Diagram showing the Dusp6 gene locus and the DNA construct used in generating transgenic zebrafish. (B, E, & H) dusp6 expression at oblong (B), dome (E), and shield stage. (C) d2EGFP mRNA expression at sphere stage. (D, F, G, I, & J) Tg(Dusp6:d2EGFP)pt6 embryos at dome (D), 30% epiboly (F & G), and shield (I & J) stage. (B-F & I) are lateral views and (H & J) are animal views. Red arrowheads mark dorsal region of the embryo.
###end p 19
###begin title 20
Expression of d2EGFP is localized to FGF signalling centres in transgenic embryos
###end title 20
###begin p 21
###xml 155 166 155 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 mRNA </italic>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf3 </italic>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-8 </italic>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 313 325 313 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP mRNA </italic>
###xml 338 346 338 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 390 397 390 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP </italic>
###xml 468 474 468 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1F</xref>
###xml 704 715 704 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 mRNA </italic>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1J</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1H</xref>
d2EGFP was first visualized as early as dome stage within the prospective dorsal region of the embryo, consistent with the restricted dorsal expression of dusp6 mRNA and with the initial expression patterns of fgf3 and -8 (compare Figure 1B to 1D) [11]. The fluorescent pattern was supported by the expression of d2EGFP mRNA as tested by in situ hybridisation (Figure 1C). At sphere stage, d2EGFP expression is maintained within the dorsal region and colocalises with dusp6 expression, a domain where the organiser (shield) eventually forms (compare Figure 1E to 1F). At 6 hpf, the highest d2EGFP expression is detected within the shield, and weakly throughout the margin, which resembles the pattern of dusp6 mRNA at this stage (compare Figure 1J to 1H).
###end p 21
###begin p 22
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 120 131 120 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP mRNA</italic>
###xml 156 163 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP </italic>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8 </italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 337 349 337 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP mRNA </italic>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8</italic>
###xml 485 491 485 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf17 </italic>
###xml 495 499 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf3</italic>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mRNA </italic>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 731 738 731 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP </italic>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2I</xref>
###xml 1024 1032 1024 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
Reporter gene expression was also analysed at later stages by in situ hybridisation performed to detect the presence of d2EGFP mRNA. At bud stage (10 hpf), d2EGFP transcripts can be detected within the posterior ventral domain and within the presumptive hindbrain, where fgf8 expression has been noted (Figure 2A) [14,30,31]. By 24 hpf, d2EGFP mRNA is detected within the MHB, pharyngeal arches, otic vesicle, retina, optic stalk and dorsal diencephalon (Figure 2B). The ligands fgf8, fgf17 and fgf3, and FGFRs are known to be expressed within these same domains, suggesting that mRNA expression of this reporter gene is under the control of FGF signalling [14,23,25,26,30,31]. In comparison to the fluorescent protein expression, d2EGFP transcripts can be detected in a much wider domain and also more prominent (compare Figure 2A to 2C and Figure 2B to 2I). One reason for the discrepancy can be attributed to the threshold level required for visualisation of d2EGFP protein as compared to the detection of transcripts by in situ hybridisation.
###end p 22
###begin p 23
###xml 42 58 42 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 58 60 58 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 58 62 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Spatial and temporal d2EGFP expression in <italic>Tg(Dusp6:d2EGFP)</italic><sup><italic>pt</italic>6 </sup>embryos</bold>
###xml 71 79 71 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A &amp; B) </bold>
###xml 96 108 96 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP mRNA </italic>
###xml 144 150 144 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C-P) </bold>
###xml 171 187 171 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 187 189 187 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 187 191 187 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 249 256 249 256 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C &amp; D)</bold>
###xml 362 373 362 373 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E, G &amp; K) </bold>
###xml 563 571 563 571 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F &amp; H) </bold>
###xml 693 697 693 697 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(H) </bold>
###xml 802 810 802 810 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(I &amp; J) </bold>
###xml 960 968 960 968 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(K &amp; L) </bold>
###xml 1092 1101 1092 1101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(K' &amp; L')</bold>
###xml 1103 1107 1103 1107 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(M) </bold>
###xml 1212 1216 1212 1216 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(N) </bold>
###xml 1335 1339 1335 1339 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(O) </bold>
###xml 1417 1421 1417 1421 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(P) </bold>
Spatial and temporal d2EGFP expression in Tg(Dusp6:d2EGFP)pt6 embryos. (A & B) Lateral views of d2EGFP mRNA expression at Bud stage and 24 hpf. (C-P) d2EGFP expression in Tg(Dusp6:d2EGFP)pt6 embryos, stages are indicated in each panel. At bud stage (C & D), d2EGFP is detected in the hindbrain (r3/r4, yellow arrowhead) and within the caudal region in the DFCs. (E, G & K) From 8- to 14-somite stages, lateral views show expression of d2EGFP in cells lining Kupffer's vesicle, within r4 (r4, yellow arrowhead) and the mid-hindbrain boundary (mhb, red arrowhead). (F & H) Dorsal views show high d2EGFP expression within the MHB, r4 and the anterior lateral plate mesoderm (alpm, red brackets). (H) At 10-somite stage initial d2EGFP expression is detected within the trigeminal ganglia (tg, blue arrow). (I & J) 24 hpf embryo showing d2EGFP expression in the MHB, trigeminal ganglia, dorsal retina (rt, white arrow) and pharyngeal endoderm (pe, yellow bracket). (K & L) 14 and 20-somite stage embryo highlighting the expression of d2EGFP in Kupffer's vesicle. Higher magnifications are show in (K' & L'). (M) Trunk region shows d2EGFP expression within the dorsal spinal cord neurons (spn, white arrow) at 24 hpf. (N) At 50 hpf expression is noted in the MHB, trigeminal ganglia, pharyngeal endoderm and otic vesicle (ot, blue bracket). (O) Ventral view of 50 hpf, showing d2EGFP expression in the jaw (white bracket). (P) At 56 hpf, strong expression in noted in the trigeminal ganglia, the jaw and also in neurons within the dorsal diencephalon.
###end p 23
###begin p 24
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 632 637 <span type="species:ncbi:10090">mouse</span>
At bud stage, fluorescent protein can be visualized within the medial neural plate, presumptive hindbrain and at a position that corresponds to the site where the Dorsal Forerunner Cells (DFCs) in the posterior domain of transgenic embryos have been described (Figure 2C &2D) [38,39]. The DFCs represent a specialized group of non-involuting cells that migrate just ahead of the shield during gastrulation and eventually forms a fluid filled structure known as Kupffer's vesicle, a transient organ particular to teleosts [38,39]. Kupffer's vesicle is thought to serve equivalent functions in establishing left-right polarity as the mouse node [40-43].
###end p 24
###begin p 25
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H</xref>
###xml 567 581 567 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C, 2E, 2G, 2K</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2K</xref>
###xml 697 702 697 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8 </italic>
###xml 789 799 789 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ace(fgf8) </italic>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 817 833 817 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 833 835 833 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 833 837 833 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 1044 1050 1044 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2K, 2L</xref>
###xml 1052 1054 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2K</xref>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2L</xref>
###xml 1268 1269 1268 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1271 1272 1271 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1274 1275 1274 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1280 1281 1280 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 1560 1561 1560 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1563 1564 1563 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1569 1570 1569 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 1573 1575 1573 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1576 1578 1576 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 599 608 <span type="species:ncbi:7955">zebrafish</span>
By the 6-somite stage, strong d2EGFP fluorescence can be detected in the MHB, the hindbrain with strongest expression in r4, the anterior lateral plate mesoderm and the Kupffer's vesicle (Figure 2E &2F). Approximately two hours later at the 10-somite stage expression of d2EGFP is located within the same domains as described for the 6-somite stage with the addition of the trigeminal ganglia (Figure 2G &2H). The expression within Kupffer's vesicle is quite striking as the structure is completely outlined by d2EGFP positive cells from the 6-somite onwards (Figure 2C, 2E, 2G, 2K and 2K'). In the zebrafish, a role for FGF signalling has been suggested in the formation of Kupffer's vesicle, as fgf8 is expressed in the DFCs at gastrulation, and this structure is absent in about 30% of ace(fgf8) mutants [44]. The Tg(Dusp6:d2EGFP)pt6 line confirms that the DFCs and Kupffer's vesicle receive FGF signals from the time when the DFCs begin to coalesce and right through to the 20-somite stage when Kupffer's vesicle begins to collapse (Figure 2K, 2L, 2K', &2L'). Time lapse imaging of the transgenic embryos shows fluorescent DFCs migration towards the posterior region of the embryo and the formation of Kupffer's Vesicle at the 6-somite stage [see Additional files 1, 2, 3 and 4]. d2EGFP expression is still noted throughout these stages and even after the collapse of Kupffer's vescles when these epithelial cells migrate towards the tail bud and contribute to mesodermal tissues such as notochord, posterior somites and the tail bud (see Additional files 2, 3 and 4) [38,39]. By the 26-somite stage, the Kupffer's vesicle cells have lost their expression of d2EGFP, suggesting that these cells no longer receive FGF signals (data not shown).
###end p 25
###begin p 26
###xml 168 174 168 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2I, 2J</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2M</xref>
###xml 304 307 304 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">erm</italic>
###xml 309 313 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pea3</italic>
###xml 315 319 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sef </italic>
###xml 323 331 323 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sprouty4</italic>
###xml 393 401 393 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 567 573 567 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2N, 2O</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2P</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2N</xref>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2N</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2O</xref>
###xml 1096 1098 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2P</xref>
###xml 1328 1330 1328 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2P</xref>
###xml 1749 1751 1749 1751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1752 1754 1752 1754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
At 24 hpf, d2EGFP can be visualized within the dorsal retina, trigeminal ganglia, otic vesicles, within the dorsal diencephalon, and dorsal spinal cord neurons (Figure 2I, 2J &2M). These domains of d2EGFP expression are consistent with expression of FGF ligands, receptors and known target genes such as erm, pea3, sef and sprouty4, suggesting that the transgenic line reports on FGF activity in vivo [13,15,24,27-29]. d2EGFP expression persists throughout the next day of development in a majority of the same domains as at 24 hpf and continues up to 56 hpf (Figure 2N, 2O &2P). The one exception is that dorsal retina expression is lost, while lens expression becomes stronger from 36 hpf onwards (Figure 2N). Expression at later stages can also be detected within the developing jaw and further refined within the pharyngeal arches and the pectoral fins (Figure 2N &2O, pectoral fins not shown). A dorsal view of a 56 hpf transgenic embryo reveals d2EGFP expression within distinct cells in the dorsal diencephalon, suggesting that these particular cells are responding to FGF signals (Figure 2P). Of particular interest is that there seems to be an asymmetric distribution of fluorescent cells with respect to the left-right axis, implying that within this region of the diencephalon, FGF signalling is asymmetrical (Figure 2P). An alternative view is that the asymmetric expression of d2EGFP is a result of anatomical or stochastic (random) differences between the left and right side of the diencephalon. Studies have shown that the left habenular nuclei is larger and the parapineal gland is situated to the left of the midline, suggesting that d2EGFP expression reflects structural difference between the left and right dorsal diencephalon [45,46].
###end p 26
###begin p 27
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 164 175 164 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 mRNA </italic>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 372 384 372 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP mRNA </italic>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 490 496 490 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
The domains of d2EGFP expression in the transgenic embryos were consistent with many of the regions where endogenous dusp6 transcripts have been detected. However, dusp6 mRNA expression was not fully recapitulated in the transgenic embryos, in particular FGF activity and dusp6 expression have been well documented within the somites and tail bud and yet no expression of d2EGFP mRNA or protein were detected in these regions (Figure 2) [11]. One explanation is that only 10 Kb of upstream Dusp6 promoter sequence was used to generate the DNA construct for transgenesis, hence it is likely that somitic and tail bud enhancers were not present within this sequence.
###end p 27
###begin p 28
###xml 99 105 99 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
In summary we have generated several transgenic lines that express d2EGFP under the control of the Dusp6 promoter, a gene that is directly regulated by FGF signalling during development. Since d2EGFP has a half life of just two hours, it is likely that domains of high d2EGFP expression represents cells that respond to active FGF signalling as opposed to cells inheriting fluorescent protein from their ancestors.
###end p 28
###begin title 29
FGF signalling controls reporter gene expression
###end title 29
###begin p 30
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8 </italic>
###xml 144 160 144 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 160 162 160 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 160 164 160 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8</italic>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 327 331 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8</italic>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 661 677 661 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 677 679 677 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 677 681 677 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 690 700 690 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ace(fgf8) </italic>
###xml 949 953 949 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A&#8211;D</xref>
###xml 1111 1115 1111 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A&#8211;D</xref>
###xml 1125 1137 1125 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">noi(pax2.1) </italic>
###xml 1343 1347 1343 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ace </italic>
###xml 1459 1463 1459 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">noi </italic>
###xml 1487 1489 1487 1489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 1493 1495 1493 1495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 584 593 <span type="species:ncbi:7955">zebrafish</span>
To test whether d2EGFP expression is responsive to experimental modulation in FGF signalling, we injected fgf8 mRNA (10 pg) into 2-4 cell stage Tg(Dusp6:d2EGFP)pt6 embryos. As expected, expression of d2EGFP was greatly expanded in fgf8-injected embryos at the gastrula stage (compare Figure 3B to 3A). Conversely, injection of fgf8-MOs (10 ng) resulted in a suppression of d2EGFP expression within the MHB and retina, while d2EGFP expression within the trigeminal ganglia was unaffected (compare Figure 3D to 3C). To confirm these findings we analyzed d2EGFP expression in two mutant zebrafish lines that exhibit defective FGF signalling [31,47]. We in-crossed Tg(Dusp6:d2EGFP)pt6 into the ace(fgf8) mutant and expression of d2EGFP within the MHB was greatly diminished in mutant embryos from 20 hpf onwards (not shown). This is clearly evident at 28 hpf when the MHB is morphologically distinguishable between wildtype siblings and mutants (Figure 4A-D). Furthermore expression within the retina and lens was absent, while expression in the optic stalk and trigeminal ganglia were unaffected at 28 hpf (Figure 4A-D). In the noi(pax2.1) mutant, d2EGFP expression was markedly reduced in the MHB, where FGF signalling is absent, however expression within the retina, lens, trigeminal ganglia and otic vesicles was unaltered. In contrast to the ace mutants, expression of d2EGFP within the optic stalk is severely reduced as this structure fails to from in the noi mutants (compare Figure 4E to 4F) Taken together, these results show that we have generated a transgenic reporter line that expresses d2EGFP under the control of FGF signalling during development.
###end p 30
###begin p 31
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D2EGFP expression is dependant on FGF signaling</bold>
###xml 49 57 49 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A &amp; B) </bold>
###xml 90 106 90 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 106 108 106 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 106 110 106 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 150 153 150 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A)</bold>
###xml 164 168 164 168 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 168 178 168 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8 mRNA </italic>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8</italic>
###xml 275 283 275 283 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C &amp; D) </bold>
###xml 327 331 327 331 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 351 355 351 355 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 355 363 355 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8-MO </italic>
D2EGFP expression is dependant on FGF signaling. (A & B) Lateral views of gastrula staged Tg(Dusp6:d2EGFP)pt6 embryos. Control uninjected is shown in (A), while in (B) fgf8 mRNA injected at the 2-cell stage. Expression of d2EGFP is greatly expanded in fgf8-injected embryos. (C & D) Lateral views of 28 hpf transgenic embryos. (C) Control MO injected (D) fgf8-MO injected embryo shows loss of d2EGFP expression within the MHB, dorsal retina and smaller otic vesicles. Red arrowhead: MHB; yellow arrow: dorsal retinal; blue arrowhead: optic stalk; red bracket: otic vesicle.
###end p 31
###begin p 32
###xml 21 30 21 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8/ace </italic>
###xml 34 45 34 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pax2.1/noi </italic>
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D2EGFP expression in <italic>fgf8/ace </italic>and <italic>pax2.1/noi </italic>mutants</bold>
###xml 54 60 54 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-F) </bold>
###xml 77 93 77 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(dusp6:d2EGFP)</italic>
###xml 93 95 93 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 93 97 93 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ace </italic>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">noi </italic>
###xml 190 198 190 198 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A &amp; B) </bold>
###xml 241 245 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ace </italic>
###xml 274 282 274 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C &amp; D) </bold>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ace </italic>
###xml 487 495 487 495 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G &amp; H) </bold>
###xml 538 542 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">noi </italic>
###xml 557 565 557 565 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E &amp; F) </bold>
###xml 638 642 638 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ace </italic>
D2EGFP expression in fgf8/ace and pax2.1/noi mutants. (A-F) Lateral views of Tg(dusp6:d2EGFP)pt6 embryos at 28 hpf crossed into ace or noi mutants. Genotype is listed in bottom left corner. (A & B) Brightfield images of wildtype sibling and ace mutant embryo, respectively. (C & D) d2EGFP expression in WT sibling and ace mutant. Note loss of d2EGFP expression within the MHB, dorsal retina, and the smaller otic vesicle, while d2EGFP expression in the trigeminal ganglia is unaffected. (G & H) Brightfield images of wildtype sibling and noi mutant embryo. (E & F) d2EGFP expression is lost in the MHB and optic stalk. In contrast to the ace mutants, expression within the dorsal retina and otic vesicles are normal.
###end p 32
###begin title 33
###xml 13 29 13 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 29 31 29 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 29 33 29 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
Treatment of Tg(Dusp6:d2EGFP)pt6 embryos with known FGF pathway inhibitors
###end title 33
###begin p 34
###xml 11 27 11 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 27 29 27 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 27 31 27 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 172 179 172 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 277 293 277 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 293 295 293 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 293 297 293 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
Given that Tg(Dusp6:d2EGFP)pt6 embryos respond to changes in FGF signalling, these embryos can provide a valuable tool to screen for molecules that modulate FGF signalling in vivo. To validate that these reporter lines can measure changes in FGF activity in a chemical screen, Tg(Dusp6:d2EGFP)pt6 embryos were treated with known inhibitors of the FGF pathway. For our studies we selected transgenic embryos at 24 hpf and treated with compounds for 8 hours. We reasoned that since the half-life of d2EGFP is 2 hours, then an inhibitor of FGF signalling should substantially reduce d2EGFP fluorescence after 6-8 hours of treatment. Furthermore, since embryos at this developmental stage (24 hpf) have already formed many of the structures that express d2EGFP such as the MHB, trigeminal ganglia and otic vesicles, then the assay would directly measure loss of d2EGFP fluorescence as a consequence of FGF inhibition and not per se a loss of these tissues.
###end p 34
###begin p 35
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 237 252 237 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 303 305 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 306 308 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 309 311 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 312 314 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 503 505 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 509 511 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 668 670 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 763 765 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 223 232 <span type="species:ncbi:7955">zebrafish</span>
###xml 237 251 <span type="species:ncbi:8355">Xenopus laevis</span>
We treated transgenic embryos with the indolinone FGF receptor inhibitor, SU5402 [Additional file 5 shows the structure of the compounds used in this study] [48]. SU5402 has been extensively used to block FGF signalling in zebrafish and Xenopus laevis embryos with doses ranging from 20 muM to 160 muM [10,27,49,50]. In this study, 1 muM SU5402 was effective at suppressing expression of d2EGFP within the trigeminal ganglia and reducing MHB fluorescence after only 8 hours of treatment (compare Figure 5A to 5B). At 5 muM of SU5402, expression of d2EGFP was markedly reduced within the MHB, and even eliminated within the dorsal retina and trigeminal ganglia (Figure 5C). At 10 muM, d2EGFP fluorescence in the transgenic embryos was completely abolished (Figure 5D).
###end p 35
###begin p 36
###xml 14 30 14 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 30 32 30 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 30 34 30 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Validation of <italic>Tg(Dusp6:d2EGFP)</italic><sup><italic>pt</italic>6 </sup>line for chemical screening</bold>
###xml 63 69 63 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-Y) </bold>
###xml 252 256 252 256 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 298 304 298 304 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B-D) </bold>
###xml 452 458 452 458 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E-H) </bold>
###xml 549 557 549 557 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(I &amp; J) </bold>
###xml 659 665 659 665 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(K-N) </bold>
###xml 774 782 774 782 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(O &amp; P) </bold>
###xml 898 904 898 904 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(Q-T) </bold>
Validation of Tg(Dusp6:d2EGFP)pt6 line for chemical screening. (A-Y) Lateral views of 30 hpf embryos treated with the compound and dose are indicated on the bottom right. The protein targets for these compounds are listed in the top right hand corner. (A) Embryo incubated in 0.5% DMSO as control. (B-D) Increasing doses of SU5402 suppressed d2EGFP expression in the MHB (red bracket), trigeminal ganglia (red arrow) and dorsal retina (red arrowhead). (E-H) Increasing doses of SU5416, a non-specific inhibitor of VEGFRs, suppressed FGF signalling. (I & J) Oxindole I another related VEGFR inhibitor also suppressed d2EGFP fluorescence in transgenic embryos. (K-N) In contrast, two compounds with similar chemical structure SU4312 and SU11652, did not block FGF signalling. (O & P) Likewise, two unrelated inhibitors of PDGFR and VEGFR, SU1433 and SU1498 also failed to suppress d2EGFP expression. (Q-T) PP2 and SU6656, two Src Kinase inhibitors suppressed FGF signalling in transgenic embryos.
###end p 36
###begin p 37
###xml 918 919 918 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1200 1202 1199 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 1303 1305 1301 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5F</xref>
###xml 1547 1549 1545 1547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5G</xref>
###xml 1551 1553 1549 1551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5H</xref>
###xml 1826 1827 1823 1824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 1842 1844 1839 1841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5I</xref>
###xml 1846 1848 1843 1845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5J</xref>
###xml 1969 1971 1966 1968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 2121 2137 2117 2133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 2137 2139 2133 2135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 2137 2141 2133 2137 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 2170 2171 2166 2167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 2185 2187 2181 2183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5K</xref>
###xml 2189 2191 2185 2187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5L</xref>
###xml 2451 2452 2447 2448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 2455 2457 2451 2453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 2458 2460 2454 2456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 2586 2588 2582 2584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5M</xref>
###xml 2590 2592 2586 2588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5N</xref>
###xml 2800 2801 2796 2797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 2804 2806 2800 2802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 2807 2809 2803 2805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 2942 2944 2938 2940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 3183 3185 3179 3181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5O</xref>
###xml 3187 3189 3183 3185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5P</xref>
###xml 612 621 <span type="species:ncbi:7955">zebrafish</span>
###xml 3142 3151 <span type="species:ncbi:7955">zebrafish</span>
Treatment with other receptor tyrosine kinase inhibitors was also performed to determine the specificity of this assay for identifying other small molecules that can modulate FGF signalling. We assessed the activity of several Vascular Endothelial Growth Factor Receptor (VEGFR) and Platelet Derived Growth Factor Receptor (PDGFR) inhibitors to reveal if these compounds, structurally related to SU5402, could suppress d2EGFP expression in the FGF reporter lines. We reasoned that most of these compounds contain the same indolinone backbone as SU5402, and therefore some would also block FGFR signalling in the zebrafish. Thus the analysis of these compounds in the FGF reporter line can determine the chemical structures that suppress FGF signalling from a family of related molecules. One of the first indolinones to undergo clinical trials was SU5416, a reported specific inhibitor for VEGFR2 [see Additional file 5] [51-53]. SU5416 was added to 24 hpf stage transgenic embryos for 6 hours to determine if this compound is specific for VEGFR versus FGFR. While this compound exhibits autofluorescence, especially within the yolk, the expression of d2EGFP did not markedly change at 1 muM (Figure 5E). In contrast at 5 muM, the trigeminal ganglia and MHB fluorescence was markedly diminished (Figure 5F). At even higher doses, SU5416 completely eliminated d2EGFP expression within the transgenic embryos, even though the treated embryos exhibited strong fluorescent yolks, the expression of d2EGFP within the MHB was clearly eliminated (Figure 5G &5H). These results suggest that SU5416 is not completely specific to VEGFR2 at these concentrations and it can block FGF signalling. Similarly, Oxindole I was also effective at blocking d2EGFP expression, however a much higher dose (40 muM) was required [see Additional file 5], and (Figure 5I &5J). SU4312 represents another indolinone inhibitor of VEGFR, which has been shown to block autophosphorylation of VEGFRs [54]. In contrast to SU5416, treatment up to 40 muM of SU4312 had little effect in the expression of d2EGFP within the MHB and trigeminal ganglia in the Tg(Dusp6:d2EGFP)pt6 embryos [see Additional file 5] and (Figure 5K &5L). A newer generation of indolinone compound was also tested to determine its specificity towards VEGFR/PDGFR versus FGFR. SU11652, has been shown to have at least 100-fold greater inhibitory effect targeting a VEGFR and PDGFR versus FGFR [see Additional file 5] [55,56]. In our assays, SU11652 did not alter d2EGFP expression suggesting that this compound does not block FGF signalling (Figure 5M &5N). We also treated transgenic embryos with two structurally unrelated VEGF signalling inhibitors, SU1498 and SU1433 (also known as AG1433) to determine the specificity of these molecules [see Additional file 5] [57-59]. Both compounds have been shown to be effective at blocking VEGFR, and to a lesser extent basic FGF in HUVEC tubulogenesis assays [58]. Treatment with high doses of SU1433 or SU1498 did not alter d2EGFP fluorescence in the transgenic embryos, suggesting that these chemically divergent compounds do not block FGF signalling in the zebrafish at the doses indicated (Figure 5O &5P).
###end p 37
###begin p 38
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 365 367 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5Q</xref>
###xml 470 472 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 473 475 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 871 875 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5R&#8211;T</xref>
###xml 878 880 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 1093 1095 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 798 803 <span type="species:ncbi:10090">mouse</span>
###xml 1075 1084 <span type="species:ncbi:7955">zebrafish</span>
We next determined the activity of Src Kinase inhibitors and their role in FGF signalling in the early embryo as previous reports have shown that several Src family members function to relay FGF signalling [60,61]. PP2, an inhibitor of several Src Kinases including Fyn and Lck as well as PDGFRs and Bcr-Abl, only mildly altered d2EGFP expression at 20 muM (Figure 5Q), a dose that is several fold higher than what has been shown to inhibit Fyn and Lck in cell culture [62,63]. SU6656, a more specific inhibitor of Src kinases, exhibited robust inhibitory activity in these assays. At concentrations of 1 muM, expression of d2EGFP was completely abolished within the MHB, trigeminal ganglia and the retina. The concentration of SU6656 was within the range that is known to be specific for blocking mouse Src kinase activity and not other related tyrosine kinases (Figure 5R-T) [63]. In fact 1 muM SU6656 is likely to inhibit only the Src members, Yes, Fyn, Src and Lyn, with Yes kinase exhibiting higher sensitivity, suggesting that Yes is required for FGF signalling in the zebrafish embryo [63].
###end p 38
###begin p 39
The results from these experiments support the use of transgenic FGF reporter lines to screen for small molecules that affect FGF signalling. Given the rapid nature of these screens as d2EGFP expression can be suppressed in just 6 hours, it is likely that a chemical screen would identify compounds that directly modulate FGF signalling.
###end p 39
###begin title 40
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
Suppression of dusp6 expression in embryos treated with FGF inhibitors
###end title 40
###begin p 41
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 254 269 254 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP</italic>
###xml 270 272 270 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 270 273 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6</sup>
###xml 313 319 313 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6F</xref>
###xml 403 409 403 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 479 485 479 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 655 660 655 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B&#8211;6F</xref>
###xml 672 678 672 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 817 822 817 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B&#8211;6F</xref>
###xml 1111 1117 1111 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 1143 1145 1143 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6G</xref>
###xml 1147 1149 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6H</xref>
To confirm that suppression of d2EGFP fluorescence reflects reduced FGF target gene transcription, we analyzed dusp6 mRNA expression in wildtype embryos treated with chemical inhibitors (Figure 6). As predicted, compounds that suppressed fluorescence in Tg(Dusp6:d2EGFP)pt6embryos also resulted in a reduction of dusp6 transcripts (Figure 6B to 6F). SU5402, SU6656, SU5416 and Oxindole I all suppressed dusp6 expression after 10hr treatment at the dose indicated. In particular, dusp6 expression within the dorsal diencephalon, pharyngeal endoderm and optic stalks were greatly reduced in embryos treated with SU5402, S6656, SU5416 and Oxindole I (Figure 6B-6F). However, dusp6 expression in the MHB was either completely eliminated by SU5402 or only mildly affected by the other compounds in treated embryos (Figure 6B-6F). These results suggest that the MHB represents a region of highest levels of FGF activity in the embryo during these developmental stages. Finally, compounds that did not alter overall d2EGFP fluorescence (SU11652 and SU4312) in treated FGF reporter line also did not exhibit changes in dusp6 transcript levels (Figure 6G &6H).
###end p 41
###begin p 42
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 0 49 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of <italic>dusp6 </italic>in chemically treated embryos</bold>
###xml 51 57 51 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-H) </bold>
###xml 168 174 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 187 191 187 191 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 205 211 205 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 285 289 285 289 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 377 381 375 379 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 381 387 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 420 426 418 424 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D-F) </bold>
###xml 489 495 487 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 507 515 505 513 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G &amp; H) </bold>
###xml 562 568 560 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
Expression of dusp6 in chemically treated embryos. (A-H) Lateral views of 24 hpf embryos treated with compounds indicated on bottom left and probed for the presence of dusp6 transcripts. (A) DMSO control, dusp6 is strongly expressed in the MHB (brackets), pharyngeal endoderm (arrow). (B) SU5402 at 10 muM greatly suppresses dusp6 transcription, while at a higher dose, 20 muM (C) dusp6 expression is almost eliminated. (D-F) SU6656, SU5416 and Oxindole I treated embryos exhibited weaker dusp6 expression. (G & H) SU4312 and SU11652 did not significantly alter dusp6 expression.
###end p 42
###begin title 43
###xml 78 90 78 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Fli:EGFP)</italic>
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
Specificity of small molecule FGF signalling inhibitors can be evaluated with Tg(Fli:EGFP)y1 transgenic embryos
###end title 43
###begin p 44
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 672 685 672 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Fli1:EGFP)</italic>
###xml 685 686 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 685 688 685 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 738 743 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fli1 </italic>
###xml 753 755 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 838 851 838 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Fli1:EGFP)</italic>
###xml 851 852 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 851 853 851 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1</sup>
###xml 1308 1310 1304 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 1311 1313 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 268 277 <span type="species:ncbi:7955">zebrafish</span>
###xml 356 365 <span type="species:ncbi:7955">zebrafish</span>
###xml 499 508 <span type="species:ncbi:7955">zebrafish</span>
###xml 1072 1080 <span type="species:ncbi:405018">cardinal</span>
Since the results obtained with the VEGFR inhibitors, SU11652, SU1433 and SU4312, were predominantly negative and did not alter d2EGFP expression in the FGF reporter embryos, we wanted to confirm that these compounds were permeable in the embryo and have an effect on zebrafish VEGR signalling. One approach is to test the activity of these compounds in a zebrafish angiogenesis assay. Such assays have been developed to screen for novel antiangiogenic compounds that can block the formation of the zebrafish intersegmental vessels (ISV), and transgenic lines that delineate the ISV have been used for such assays [35,64]. For our studies we analysed ISV outgrowth in the Tg(Fli1:EGFP)y1 line that expresses eGFP under the control of the Fli1 promoter [65]. To determine the effects of these VEGFR inhibitors on ISV outgrowth, we treated Tg(Fli1:EGFP)y1transgenic embryos at 24 hpf for 8 hours. Treatment within this limited temporal window would reveal whether a compound could specifically block VEGFR signalling and ISV outgrowth as somites, dorsal aorta and posterior cardinal vein would have already been established at 24 hpf. Furthermore previous studies have highlighted the requirement for active VEGFR signalling that is relayed through PLCgamma and AKT to form the ISV using a similar time frame [64-66].
###end p 44
###begin p 45
###xml 17 30 17 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Fli1:EGFP)</italic>
###xml 30 31 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B&#8211;D</xref>
###xml 612 628 611 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 628 630 627 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 628 632 627 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 648 650 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
###xml 838 851 837 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Fli1:EGFP)</italic>
###xml 851 852 850 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 851 854 850 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 920 922 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7F</xref>
###xml 211 220 <span type="species:ncbi:7955">zebrafish</span>
We first treated Tg(Fli1:EGFP)y1 embryos with SU1433, SU11652 and SU4312, compounds that did not alter fluorescence in the FGF reporter embryos, to determine if these compounds can block VEGFR signalling in the zebrafish. As predicted, all three compounds suppressed ISV outgrowth in the transgenic embryos, thus exhibiting specificity towards VEGFRs, and confirming that these compounds are permeable in the embryo (Figure 7B-D). Similar effects on ISV outgrowth were noted with Oxindole I, a compound that blocked FGF signalling, however at a much lower dose (5 muM) that was required to block fluorescence in Tg(Dusp6:d2EGFP)pt6 embryos (Figure 7E). This result suggests that Oxindole I has a higher activity towards VEGFR signalling. We next assayed the effects of the FGF receptor inhibitor, SU5402, on ISV outgrowth. SU5402 treated Tg(Fli1:EGFP)y1 embryos also resulted in the suppression of ISV formation (Figure 7F). The original description of SU5402 had provided evidence that this compound would interact with the ATP binding domain of the VEGFR and was supported by unpublished data that SU5402 did block VEGFR signalling in tissue culture experiments, yet SU5402 is often used as a specific FGFR inhibitor. Thus we stress that the effects of SU5402 treatment may not exclusively reflect a blockade of FGFRs.
###end p 45
###begin p 46
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Specificity of Indolinones towards FGFR versus VEGFR signalling</bold>
###xml 65 71 65 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-H) </bold>
###xml 101 114 101 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Fli1:EGFP)</italic>
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 178 182 178 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 274 278 274 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 293 297 292 296 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 306 310 305 309 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 317 321 316 320 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E) </bold>
###xml 333 337 332 336 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F) </bold>
###xml 349 353 348 352 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G) </bold>
###xml 417 421 416 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(H) </bold>
Specificity of Indolinones towards FGFR versus VEGFR signalling. (A-H) Lateral trunk views of 32 hpf Tg(Fli1:EGFP)y1 embryos treated with the chemicals shown on the bottom left. (A) DMSO control shows embryo with normal expression of EGFP within the intersegmental vessels. (B) 20 muM SU1433, (C) SU11652, (D) SU4312 (E) Oxindole I, (F) SU5402, and (G) SU5416 all suppressed ISV outgrowth as indicated by red arrows. (H) SU6656 in contrast did not alter ISV formation.
###end p 46
###begin p 47
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7F</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7G</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 298 310 298 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Fli:EGFP)</italic>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 310 313 310 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7H</xref>
SU4312 and SU5416, two compounds that have previously been shown to inhibit VEGF signalling also inhibited ISV outgrowth (Figure 7F &7G) [51,54,67]. Thus SU5416 strongly suppressed both VEGF and FGF signalling in our assays, while SU4312 was specific for VEGF signalling. In contrast, treatment of Tg(Fli:EGFP)y1 embryos with the inhibitor of Src kinases, SU6656, did not block ISV outgrowth, suggesting that VEGF signalling does not require Src kinases to direct vessel formation (Figure 7H).
###end p 47
###begin p 48
###xml 109 117 109 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fli1 </italic>
###xml 364 369 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fli1 </italic>
###xml 418 422 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B&#8211;G</xref>
###xml 578 583 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fli1 </italic>
###xml 733 735 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8H</xref>
###xml 499 508 <span type="species:ncbi:7955">zebrafish</span>
To confirm our findings that VEGFR inhibitors did indeed block intersegmental vessel outgrowth, we performed in situ hybridisation studies to detect the presence of these vessels through fli1 expression. Treatment of embryos with 1 muM Oxindole 1, 10 muM SU5416, 20 muM SU4312, 1 muM SU5402, or with 20 muM SU11652 prevented ISV formation as determined by loss of fli1 expression in the intersegmental sprouts (Figure 8B-G). Again these results confirm that SU5402 can block VEGFR signalling in the zebrafish and is not a specific inhibitor of FGFRs. In contrast, expression of fli1 within the ISV was unaffected in embryos treated with 10 muM SU6656, confirming the notion that Src kinases are not required in ISV outgrowth (Figure 8H).
###end p 48
###begin p 49
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fli1 </italic>
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of <italic>fli1 </italic>in intersegmental vessels in indolinone treated embryos</bold>
###xml 76 82 76 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-H) </bold>
###xml 105 114 105 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fli mRNA </italic>
###xml 141 145 141 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 190 196 190 196 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B-G) </bold>
###xml 276 280 276 280 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(H) </bold>
Expression of fli1 in intersegmental vessels in indolinone treated embryos. (A-H) Lateral trunk views of fli mRNA expression within the ISV. (A) DMSO control shows vessel sprouts at 28 hpf. (B-G) Embryos treated with the compounds indicated show loss of ISV sprouts, while in (H) SU6656 did not affect these vessels.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1033 1046 1033 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(twhh:GFP) </italic>
###xml 1184 1186 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 45 54 <span type="species:ncbi:7955">zebrafish</span>
In this paper we present the generation of a zebrafish transgenic line that reports on FGF signalling during embryonic development. Expression of d2EGFP in these embryos is regulated by FGF signalling and maps to domains where activated ERKs have been detected [7-12]. Time-lapse imaging of transgenic embryos shows the dynamic expression of d2EGFP throughout embryogenesis. These movies demarcate the formation of Kupffer's vesicle, as d2EGFP labels the DFCs from gastrulation onwards. Since Kupffer's vesicle plays a critical role in the determination of left-right polarity these lines will provide a valuable tool to access the integrity of Kupffer's vesicle formation in left-right polarity mutants [41,42]. Furthermore, these lines provides a way to identify DFCs in post-gastrulation but pre-Kupffer's vesicle stages in live embryos. To our knowledge this is the only line that specifically labels the DFCs with fluorescence as they migrate during gastrulation to eventually form Kupffer's vesicle. This is in contrast to the Tg(twhh:GFP) line that also expresses GFP in Kupffer's vesicle, as GFP expression was only detected once the vesicle had formed at the 6-somite stage [68].
###end p 51
###begin p 52
###xml 60 71 60 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 mRNA </italic>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
While a majority of the d2EGFP expression resembles that of dusp6 mRNA during development, a notable exception is the lack of d2EGFP expression within the developing somites and tail bud, two domains where FGFs and Erk activation have been described [3,12,31]. Since only 10 Kb of upstream promoter sequence was used in generating the reporter construct, it is likely that the somitic and tail bud enhancers elements are not part of this sequence.
###end p 52
###begin p 53
###xml 345 350 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 463 469 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 615 621 615 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 825 841 825 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 841 843 841 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 841 845 841 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 942 949 942 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
The expression of d2EGFP is under the control of FGF signalling as manipulation of FGF activity in transgenic embryos resulted in altered d2EGFP expression. These lines will provide useful tools to analyze the integrity of FGF signalling under experimental conditions such as antisense MOs injections or in mutant strains. Previously, Balciunas et al. described a transposon-mediated enhancer trapped line that contains an EGFP reporter inserted 30 Kb within the Dusp6 locus (ET7 line) [69]. In the ET7 transgenic embryos, EGFP is detected within the MHB, pharyngeal endoderm and somites at 24 hpf, suggesting that Dusp6 enhancers may regulate the expression of eGFP [69]. However, it has not been demonstrated if EGFP expression in the ET7 embryos can respond to experimental changes in FGF signalling [69]. We believe that Tg(Dusp6:d2EGFP)pt6 represent the first description of vertebrate transgenic embryos that can report on FGF activity in vivo.
###end p 53
###begin p 54
###xml 1302 1304 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 1305 1307 1305 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 938 947 <span type="species:ncbi:7955">zebrafish</span>
We have used these transgenic lines to validate an approach to screen for small molecules that can modulate FGF signalling. Our results show that within 6 hours of treatment with the FGFR inhibitor, SU5402, complete suppression of de2GFP expression ensued, confirming that these lines can rapidly identify compounds that modulate FGF signal transduction in the embryo. Since FGFRs are members of a larger family of receptor tyrosine kinases we wanted to determine if compounds that are structurally related to SU5402 could also block FGF signalling in the embryo. We determined the specificity of several VEGFR and PDGFR inhibitors that contain the same indolinone backbone as SU5402. From our studies it was clear that SU5416 and Oxindole I, two inhibitors of VEGFR could block d2EGFP expression in the FGF reporter embryos. Furthermore, from these studies we also revealed a putative role for Src kinases in relaying FGF signals in the zebrafish as treatment with Src kinase inhibitors, PP2 and SU6656, suppressed d2EGFP fluorescence. Since several members of this kinase family are expressed early and within cells that receive FGF signals in the developing embryo, including Yes and Fyn, the preferred targets of SU6656, it is reasonable to think that these Kinases are involved in FGF signalling [70-72].
###end p 54
###begin p 55
###xml 42 55 42 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Fli1:EGFP)</italic>
###xml 55 56 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1024 1026 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1161 1163 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1164 1166 1164 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 869 878 <span type="species:ncbi:7955">zebrafish</span>
We have coupled the pilot screen with the Tg(Fli1:EGFP)y1 transgenic line to assay the specificity of these compounds between FGFR and VEGFR signalling. We confirm that SU5416, SU4312, SU11652, Oxindole I and surprisingly SU5402 exhibited inhibitory effects on ISV outgrowth and probably a result of VEGFR inhibition. In the original study, a crystal structure of SU5402 complexed with the FGFR1 kinase domain highlighted the exact peptide residues that interfaced with the compound [48]. Since these residues are also highly conserved with the VEGFRs kinase domain, it was postulated that SU5402 could interact with the VEGFRs [48]. Furthermore the authors refer to unpublished observations that SU5402 did inhibit VEGFR signalling in living cells [48]. Our studies reveal that SU5402 can block ISV outgrowth, which we interpret as a result of VEGFR inhibition in the zebrafish embryo. Alternatively, our data could imply that FGFRs are required for ISV outgrowths given that FGFs are known to play a role in angiogenesis [53]. However from the published literature, FGFR1-4 are not expressed in the ISV to support the role for this pathway in vasculogenesis [25,26]. SU5402 has been used extensively as a FGFR inhibitor in many studies. In light of these findings, other experiments should be considered to test whether SU5402 might also block VEGFR signalling to elicit the observed phenotypes.
###end p 55
###begin title 56
Conclusion
###end title 56
###begin p 57
###xml 61 77 61 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 77 79 77 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 77 80 77 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6</sup>
###xml 502 515 502 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Fli1:EGFP)</italic>
###xml 515 516 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 515 518 515 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
###xml 791 798 791 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 50 59 <span type="species:ncbi:7955">zebrafish</span>
This study describes the generation of transgenic zebrafish, Tg(Dusp6:d2EGFP)pt6, that reports on FGF activity during development. The expression of d2EGFP mirrors the expression of several FGF ligands in the early embryo and will provide a tool to analyse FGF signalling under various experimental conditions. We have performed a pilot screen to validate these lines in chemical screens to identify novel compounds that can modulate FGF activity. This rapid screening protocol can be coupled with the Tg(Fli1:EGFP)y1 line to eliminate compounds that can potentially cross react with the VEGFR pathway. Finally, acridine orange staining will further eliminate toxic compounds, thus by following these procedures it is possible to identify chemicals that specifically modulate FGF signalling in vivo.
###end p 57
###begin title 58
Methods
###end title 58
###begin title 59
###xml 14 31 14 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP) </italic>
###xml 31 40 <span type="species:ncbi:7955">zebrafish</span>
Generation of Tg(Dusp6:d2EGFP) zebrafish
###end title 59
###begin p 60
###xml 2 8 2 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 417 431 417 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pDusp6:d2EGFP </italic>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 873 889 873 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 889 891 889 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 889 893 889 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
A Dusp6 BAC clone was identified by PCR from BAC DNA pools as directed by manufacturers protocols (Genome Systems). A 10 Kb Kpn1 fragment was identified that contain parts of Exon 1 (441 bp) and approximately 9.5 Kb of upstream promoter sequence (see Figure 1A). This Kpn1 fragment was subcloned into the Kpn1 site of pSce1d2EGFP vector (pSce1 vector with d2EGFP cDNA cloned into the multiple cloning site). 20 pg of pDusp6:d2EGFP plasmid DNA was injected into the 1-cell embryo with I-Sce 1 (New England Biolabs, Ipswich, MA) restriction enzyme as described in [37]. These Founder F0 injected embryos were raised to adulthood and incrossed to identify transgenic founders. We identified 10 founder lines that expressed d2EGFP within regions of known FGF activity in the developing embryo. Four lines exhibited strong expression throughout development and were maintained. Tg(Dusp6:d2EGFP)pt6 was used predominantly in this study.
###end p 60
###begin title 61
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish Microinjection of RNA and antisense Morpholinos
###end title 61
###begin p 62
###xml 6 15 6 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8 mRNA</italic>
###xml 78 86 78 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fgf8-MO </italic>
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et. al </italic>
###xml 213 219 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et. al</italic>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
10 pg fgf8 mRNA, 20 ng control-MO(5'-CCTCTTACCTCAGTTACAATTTATA-3'), and 10 ng fgf8-MO (5'-GAGTCTCATGTTTATAGCCTCAGTA-3') was injected into the 2-cell stage transgenic embryos as described by Tsang et. al and Araki et. al, respectively [13,73]. Morpholinos were obtained from Gene-tools inc. (Philomath, OR). Embryos were incubated for the desired stage before visualisation under a Leica stereomicroscope and photographed by a Retiga Exi camera (Qimaging, Burnaby, BC Canada). Images were analyzed in Photoshop CS (Adobe, San Jose, CA).
###end p 62
###begin title 63
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
In situ hybridisation
###end title 63
###begin p 64
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d2EGFP</italic>
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp6 </italic>
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fli1 </italic>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 149 157 149 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In Situ </italic>
###xml 191 197 191 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et. al</italic>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish embryos were fixed in 4% paraformaldehyde and whole mount in situ hybridisation was preformed with d2EGFP, dusp6 and fli1 RNA probes [11]. In Situ methodology as described in Kudoh et. al. [14].
###end p 64
###begin title 65
Chemical treatment of transgenic embryos
###end title 65
###begin p 66
###xml 5 21 5 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 21 23 21 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 21 25 21 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
###xml 1058 1070 1057 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Fli:EGFP)</italic>
###xml 1070 1071 1069 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 1070 1073 1069 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
Five Tg(Dusp6:d2EGFP)pt6 embryos at 24 hpf were arrayed into individual wells in a 96-well plate. 100 mul of E3, 0.5% DMSO solution was added along with compound at the dose indicated. SU5402 was kindly provided by Pfizer. SU1498, SU11652, AG1433 (SU1433), SU6656, Oxindole I, were all obtained from Calbiochem (EMD biosciences, Inc. San Diego, CA) and SU5416, SU4312 from Sigma-Aldrich (St. Louis, MO). Embryos were analyzed at 6-8 hour post treatment after manual dechorinonation and treatment with tricaine to immobilise for photography. Treated embryos were photographed under the same settings for exposure, gain and magnification for each picture using a MZFLIII (leica) microscrope and fluorescent illumination for GFP using endow cube (Chroma Technology Corp., Rockingham, VT). Qimaging software and the Retiga Exi camera (Qimaging, Burnaby, BC Canada) was used to capture the images. Each experiment was repeated three times to show reproducibility of the assay and at least 4 of the 5 treated embryos exhibited the same phenotype. For treatment of Tg(Fli:EGFP)y1 embryos, five transgenic embryos were placed into 96-well plates at 24 hpf and incubated with compound until 32 hpf. Treated embryos were manually dechorionated and photographed as described for the FGF reporter assay. Images were analyzed in Adobe Photoshop CS (San Jose, CA) and false coloured under the same parameters.
###end p 66
###begin title 67
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish imaging
###end title 67
###begin p 68
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 16 18 16 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 16 20 16 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
Tg(Dusp6:d2EGFP)pt6 embryos were placed into a MatTek glass bottom culture dish (MatTek Corp.) at gastrula stage (6 hpf) and held in place with 1% low melting point agarose. Embryos were photographed under low magnification differential contract (DIC) microscopy and fluorescent illumination for GFP using endow cube (Chroma Technology Corp., Rockingham, VT) at 5 min intervals until 24 hpf. Images were analyzed and processed into movies with Metamorph imaging software (Molecular Devices, Dowlingtown PA).
###end p 68
###begin title 69
Authors' contributions
###end title 69
###begin p 70
###xml 131 137 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6 </italic>
###xml 421 429 421 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
The experiments described in this paper were planned, conducted and analyzed by GAM, SCW and MT as a joint effort. MT isolated the Dusp6 promoter, generated the transgenic lines, described the expression of d2EGFP, and performed experiments to determine that these lines are responsive to FGFs. MT and GAM conceived the chemical screen test and GAM performed the experiments detailed in the pilot chemical screen and the in situ hybridisation. SCW was responsible for the time-lapse imaging of these lines. MT drafted the manuscript and all authors read and approved the final version.
###end p 70
###begin title 71
Supplementary Material
###end title 71
###begin title 72
Additional file 1
###end title 72
###begin p 73
###xml 87 103 87 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 103 105 103 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 103 107 103 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
Movie showing d2EGFP expression in Dorsal Forerunner Cells (DFCs). Movie of developing Tg(Dusp6:d2EGFP)pt6 embryo from late gastrula stage until bud stage. The movie shows a group of fluorescent cells, the DFCs as they coalesce towards the caudal region of the embryo.
###end p 73
###begin p 74
Click here for file
###end p 74
###begin title 75
Additional file 2
###end title 75
###begin p 76
###xml 91 107 91 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 107 109 107 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 107 111 107 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
Movie showing d2EGFP expression in the developing embryo. Time-laspe imaging of developing Tg(Dusp6:d2EGFP)pt6 embryo from gastrula stage until 24-somite stage. Movie highlights the dynamic expression of d2EGFP within the developing embryo. The movie of the fluorescent embryo was overlayed onto the DIC-imaged movie to show clearly the developing embryo. Note expression of d2EGFP within the developing hindbrain, MHB and Kupffer's vesicle.
###end p 76
###begin p 77
Click here for file
###end p 77
###begin title 78
Additional file 3
###end title 78
###begin p 79
###xml 76 92 76 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Dusp6:d2EGFP)</italic>
###xml 92 94 92 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pt</italic>
###xml 92 96 92 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>pt</italic>6 </sup>
Movie showing d2EGFP expression in Kupffer's vesicle. Time-laspe imaging of Tg(Dusp6:d2EGFP)pt6 embryo from gastrula stage until 24-somite stage. GFP movie showing the formation of Kupffer's vesicle from the 6-somite stage right until after this structure collapses at the 20-somite stage. Note Kupffer's vesicle cells collapse inwards and begin to migrate towards the tail bud.
###end p 79
###begin p 80
Click here for file
###end p 80
###begin title 81
Additional file 4
###end title 81
###begin p 82
Movie showing d2EGFP expression in Kupffer's vesicle with DIC overlay. This is the same movie as Supplemental Movie 3, but overlayed with the DIC-imaged movie to show structures of the developing embryo.
###end p 82
###begin p 83
Click here for file
###end p 83
###begin title 84
Additional file 5
###end title 84
###begin p 85
Diagram of the small molecules used in this study. The majority of the chemicals used in the pilot screen are related in structure and contain the indolinone backbone as described for SU5402.
###end p 85
###begin p 86
Click here for file
###end p 86
###begin title 87
Acknowledgements
###end title 87
###begin p 88
###xml 249 262 249 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tg(Fli1:EGFP)</italic>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">y</italic>
###xml 262 265 262 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>y</italic>1 </sup>
We would like to thanks Drs Tom Smithgall, Michael Rebagliati, Neil Hukriede, Beth Roman and Igor Dawid for insightful discussion, and critical reading of the manuscript. SU5402 was kindly provided by Pfizer. The I-Sce-I meganuclease vector and the Tg(Fli1:EGFP)y1 line was provided by Dr J. Wittbrodt and Dr Brant Weinstein, respectively. This work is supported by grants from the American Heart Association (0565400U) and Pennsylvania Department of Health to MT, and from the National Institutes of Health (1U54 RR02241-01) to SCW.
###end p 88
###begin article-title 89
The midbrain--hindbrain boundary organizer
###end article-title 89
###begin article-title 90
The roles of FGFs in the early development of vertebrate limbs
###end article-title 90
###begin article-title 91
###xml 55 64 <span type="species:ncbi:7955">zebrafish</span>
A role for FGF-8 in the dorsoventral patterning of the zebrafish gastrula
###end article-title 91
###begin article-title 92
Functions and regulations of fibroblast growth factor signaling during embryonic development
###end article-title 92
###begin article-title 93
Fibroblast growth factors, their receptors and signaling
###end article-title 93
###begin article-title 94
Promotion and attenuation of FGF signaling through the Ras-MAPK pathway
###end article-title 94
###begin article-title 95
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Spatial and temporal patterns of ERK signaling during mouse embryogenesis
###end article-title 95
###begin article-title 96
Beta-catenin, MAPK and Smad signaling during early Xenopus development
###end article-title 96
###begin article-title 97
Fgf/MAPK signalling is a crucial positional cue in somite boundary formation
###end article-title 97
###begin article-title 98
###xml 99 108 <span type="species:ncbi:7955">zebrafish</span>
Fgf signalling through MAPK cascade is required for development of the subpallial telencephalon in zebrafish embryos
###end article-title 98
###begin article-title 99
###xml 43 52 <span type="species:ncbi:7955">zebrafish</span>
A role for MKP3 in axial patterning of the zebrafish embryo
###end article-title 99
###begin article-title 100
###xml 88 93 <span type="species:ncbi:9031">chick</span>
A spatial and temporal map of FGF/Erk1/2 activity and response repertoires in the early chick embryo
###end article-title 100
###begin article-title 101
Identification of Sef, a novel modulator of FGF signalling
###end article-title 101
###begin article-title 102
###xml 28 37 <span type="species:ncbi:7955">zebrafish</span>
A gene expression screen in zebrafish embryogenesis
###end article-title 102
###begin article-title 103
Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling
###end article-title 103
###begin article-title 104
###xml 70 75 <span type="species:ncbi:9031">chick</span>
Negative feedback regulation of FGF signaling levels by Pyst1/MKP3 in chick embryos
###end article-title 104
###begin article-title 105
MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb
###end article-title 105
###begin article-title 106
Mkp3 is a negative feedback modulator of Fgf8 signaling in the mammalian isthmic organizer
###end article-title 106
###begin article-title 107
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development
###end article-title 107
###begin article-title 108
Negative feedback predominates over cross-regulation to control ERK MAPK activity in response to FGF signalling in embryos
###end article-title 108
###begin article-title 109
###xml 72 77 <span type="species:ncbi:9031">chick</span>
Experimental study of MAP kinase phosphatase-3 (Mkp3) expression in the chick neural tube in relation to Fgf8 activity
###end article-title 109
###begin article-title 110
###xml 142 147 <span type="species:ncbi:9031">chick</span>
Feedback interactions between MKP3 and ERK MAP kinase control scleraxis expression and the specification of rib progenitors in the developing chick somite
###end article-title 110
###begin article-title 111
Requirement for endoderm and FGF3 in ventral head skeleton formation
###end article-title 111
###begin article-title 112
###xml 75 84 <span type="species:ncbi:7955">zebrafish</span>
sprouty4 acts in vivo as a feedback-induced antagonist of FGF signaling in zebrafish
###end article-title 112
###begin article-title 113
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish fgfr1 is a member of the fgf8 synexpression group and is required for fgf8 signalling at the midbrain-hindbrain boundary
###end article-title 113
###begin article-title 114
###xml 74 83 <span type="species:ncbi:7955">zebrafish</span>
###xml 84 95 <span type="species:ncbi:7955">Danio rerio</span>
Expression of the FGF receptor 2 gene (fgfr2) during embryogenesis in the zebrafish Danio rerio
###end article-title 114
###begin article-title 115
###xml 99 108 <span type="species:ncbi:7955">zebrafish</span>
Tight transcriptional control of the ETS domain factors Erm and Pea3 by Fgf signaling during early zebrafish development
###end article-title 115
###begin article-title 116
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish pea3 and erm are general targets of FGF8 signaling
###end article-title 116
###begin article-title 117
###xml 66 75 <span type="species:ncbi:7955">zebrafish</span>
Expression of the Ets transcription factors erm and pea3 in early zebrafish development
###end article-title 117
###begin article-title 118
###xml 60 69 <span type="species:ncbi:7955">zebrafish</span>
Overlapping and distinct functions provided by fgf17, a new zebrafish member of the Fgf8/17/18 subgroup of Fgfs
###end article-title 118
###begin article-title 119
###xml 19 28 <span type="species:ncbi:7955">zebrafish</span>
Fgf8 is mutated in zebrafish acerebellar (ace) mutants and is required for maintenance of midbrain-hindbrain boundary development and somitogenesis
###end article-title 119
###begin article-title 120
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish-based small molecule discovery
###end article-title 120
###begin article-title 121
Small molecule developmental screens reveal the logic and timing of vertebrate development
###end article-title 121
###begin article-title 122
###xml 30 39 <span type="species:ncbi:7955">zebrafish</span>
In vivo drug discovery in the zebrafish
###end article-title 122
###begin article-title 123
###xml 59 68 <span type="species:ncbi:7955">zebrafish</span>
Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay
###end article-title 123
###begin article-title 124
Generation of destabilized green fluorescent protein as a transcription reporter
###end article-title 124
###begin article-title 125
I-SceI meganuclease mediates highly efficient transgenesis in fish
###end article-title 125
###begin article-title 126
###xml 64 73 <span type="species:ncbi:7955">zebrafish</span>
A cluster of noninvoluting endocytic cells at the margin of the zebrafish blastoderm marks the site of embryonic shield formation
###end article-title 126
###begin article-title 127
###xml 56 65 <span type="species:ncbi:7955">zebrafish</span>
Specification of cell fates at the dorsal margin of the zebrafish gastrula
###end article-title 127
###begin article-title 128
###xml 114 123 <span type="species:ncbi:7955">zebrafish</span>
The Cerberus/Dan-family protein Charon is a negative regulator of Nodal signaling during left-right patterning in zebrafish
###end article-title 128
###begin article-title 129
###xml 58 67 <span type="species:ncbi:7955">zebrafish</span>
Kupffer's vesicle is a ciliated organ of asymmetry in the zebrafish embryo that initiates left-right development of the brain, heart and gut
###end article-title 129
###begin article-title 130
###xml 31 40 <span type="species:ncbi:7955">zebrafish</span>
Cilia-driven fluid flow in the zebrafish pronephros, brain and Kupffer's vesicle is required for normal organogenesis
###end article-title 130
###begin article-title 131
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
The zebrafish nodal-related gene southpaw is required for visceral and diencephalic left-right asymmetry
###end article-title 131
###begin article-title 132
Roles for fgf8 signaling in left-right patterning of the visceral organs and craniofacial skeleton
###end article-title 132
###begin article-title 133
###xml 39 48 <span type="species:ncbi:7955">zebrafish</span>
Leaning to the left: laterality in the zebrafish forebrain
###end article-title 133
###begin article-title 134
###xml 89 98 <span type="species:ncbi:7955">zebrafish</span>
A nodal signaling pathway regulates the laterality of neuroanatomical asymmetries in the zebrafish forebrain
###end article-title 134
###begin article-title 135
###xml 44 53 <span type="species:ncbi:7955">zebrafish</span>
A series of no isthmus (noi) alleles of the zebrafish pax2.1 gene reveals multiple signaling events in development of the midbrain-hindbrain boundary
###end article-title 135
###begin article-title 136
Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors
###end article-title 136
###begin article-title 137
Neural induction in Xenopus requires early FGF signalling in addition to BMP inhibition
###end article-title 137
###begin article-title 138
Fgf3 and Fgf8 are required together for formation of the otic placode and vesicle
###end article-title 138
###begin article-title 139
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types
###end article-title 139
###begin article-title 140
###xml 118 126 <span type="species:ncbi:9606">patients</span>
Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases
###end article-title 140
###begin article-title 141
FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition
###end article-title 141
###begin article-title 142
Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residues
###end article-title 142
###begin article-title 143
Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors
###end article-title 143
###begin article-title 144
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
Effect of angiogenesis inhibitors on oestrogen-mediated endometrial endothelial cell proliferation in the ovariectomized mouse
###end article-title 144
###begin article-title 145
Flk-1 as a target for tumor growth inhibition
###end article-title 145
###begin article-title 146
SU1498, an inhibitor of vascular endothelial growth factor receptor 2, causes accumulation of phosphorylated ERK kinases and inhibits their activity in vivo and in vitro
###end article-title 146
###begin article-title 147
Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo
###end article-title 147
###begin article-title 148
FGF signals for cell proliferation and migration through different pathways
###end article-title 148
###begin article-title 149
Xenopus FRS2 is involved in early embryogenesis in cooperation with the Src family kinase Laloo
###end article-title 149
###begin article-title 150
The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases
###end article-title 150
###begin article-title 151
SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling
###end article-title 151
###begin article-title 152
###xml 38 47 <span type="species:ncbi:7955">zebrafish</span>
Dissection of angiogenic signaling in zebrafish using a chemical genetic approach
###end article-title 152
###begin article-title 153
###xml 67 76 <span type="species:ncbi:7955">zebrafish</span>
In vivo imaging of embryonic vascular development using transgenic zebrafish
###end article-title 153
###begin article-title 154
phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development
###end article-title 154
###begin article-title 155
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish angiogenesis: a new model for drug screening
###end article-title 155
###begin article-title 156
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
###xml 127 136 <span type="species:ncbi:7955">zebrafish</span>
Zebrafish tiggy-winkle hedgehog promoter directs notochord and floor plate green fluorescence protein expression in transgenic zebrafish embryos
###end article-title 156
###begin article-title 157
###xml 21 30 <span type="species:ncbi:7955">zebrafish</span>
Enhancer trapping in zebrafish using the Sleeping Beauty transposon
###end article-title 157
###begin article-title 158
###xml 63 72 <span type="species:ncbi:7955">zebrafish</span>
Role of Fyn kinase in signaling associated with epiboly during zebrafish development
###end article-title 158
###begin article-title 159
Fyn/Yes and non-canonical Wnt signalling converge on RhoA in vertebrate gastrulation cell movements
###end article-title 159
###begin article-title 160
###xml 32 41 <span type="species:ncbi:7955">zebrafish</span>
Role of Yes kinase during early zebrafish development
###end article-title 160
###begin article-title 161
Morpholino-induced knockdown of fgf8 efficiently phenocopies the acerebellar (ace) phenotype
###end article-title 161

